Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology
- PMID: 37419224
- DOI: 10.1016/j.jep.2023.116879
Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology
Abstract
Ethnopharmacological relevance: Globally, plant materials are widely used as an additional and alternative therapy for the treating of diverse diseases. Ulcerative colitis (UC) is a chronic, recurrent and nonspecific inflammation of the bowel, referred to as "modern intractable disease" according to the World Health Organization. With the continuous development of theoretical research in Traditional Chinese Medicine (TCM) and the advantages of TCM in terms of low side effects, TCM has shown great progress in the research of treating UC.
Aim of this review: This review aimed to explore the correlation between intestinal microbiota and UC, summarize research advances in TCM for treating UC, and discuss the mechanism of action of TCM remedies in regulating intestinal microbiota and repairing damaged intestinal barrier, which will provide a theoretical basis for future studies to elucidate the mechanism of TCM remedies based on gut microbiota and provide novel ideas for the clinical treatment of UC.
Methods: We have collected and collated relevant articles from different scientific databases in recent years on the use of TCM in treating UC in relation to intestinal microecology. Based on the available studies, the therapeutic effects of TCM are analysed and the correlation between the pathogenesis of UC and intestinal microecology is explored.
Results: TCM is used to further protect the intestinal epithelium and tight junctions, regulate immunity and intestinal flora by regulating intestinal microecology, thereby achieving the effect of treating UC. Additionally, TCM remedies can effectively increase the abundance of beneficial bacteria that produce short-chain fatty acids, decrease the abundance of pathogenic bacteria, restore the balance of intestinal microbiota, and indirectly alleviate intestinal mucosal immune barrier dysfunction and promote the repair of damaged colorectal mucosa.
Conclusion: Intestinal microbiota is closely related to UC pathogenesis. The alleviation of intestinal dysbiosis can be a potential novel therapeutic strategy for UC. TCM remedies can exert protective and therapeutic effects on UC through various mechanisms. Although intestinal microbiota can aid in the identification of different TCM syndromes types, further studies are needed using modern medical technology. This will improve the clinical therapeutic efficacy of TCM remedies in UC and promote the application of precision medicine.
Keywords: Intestinal barrier; Intestinal microecology; Mechanism; Traditional Chinese medicine; Ulcerative colitis.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declared that there are no conflicts of interest.
Similar articles
-
Potential activity of Traditional Chinese Medicine against Ulcerative colitis: A review.J Ethnopharmacol. 2022 May 10;289:115084. doi: 10.1016/j.jep.2022.115084. Epub 2022 Feb 5. J Ethnopharmacol. 2022. PMID: 35134488 Review.
-
Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota.J Ethnopharmacol. 2022 Nov 15;298:115640. doi: 10.1016/j.jep.2022.115640. Epub 2022 Aug 24. J Ethnopharmacol. 2022. PMID: 36030029
-
Inhibition of ferroptosis: A new direction in the treatment of ulcerative colitis by traditional Chinese medicine.J Ethnopharmacol. 2024 Apr 24;324:117787. doi: 10.1016/j.jep.2024.117787. Epub 2024 Jan 20. J Ethnopharmacol. 2024. PMID: 38253272 Review.
-
Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice.J Ethnopharmacol. 2023 Feb 10;302(Pt B):115919. doi: 10.1016/j.jep.2022.115919. Epub 2022 Nov 7. J Ethnopharmacol. 2023. PMID: 36356716
-
Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review.Front Pharmacol. 2023 Oct 24;14:1273407. doi: 10.3389/fphar.2023.1273407. eCollection 2023. Front Pharmacol. 2023. PMID: 37942490 Free PMC article. Review.
Cited by
-
Traditional Chinese medicine treats ulcerative colitis by regulating gut microbiota, signaling pathway and cytokine: Future novel method option for pharmacotherapy.Heliyon. 2024 Mar 6;10(6):e27530. doi: 10.1016/j.heliyon.2024.e27530. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38501018 Free PMC article. Review.
-
Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases.Front Immunol. 2024 Mar 20;15:1370658. doi: 10.3389/fimmu.2024.1370658. eCollection 2024. Front Immunol. 2024. PMID: 38571945 Free PMC article. Review.
-
Evaluation of Indigo Naturalis Prepared Using a Novel Method: Therapeutic Effects on Experimental Ulcerative Colitis in Mice.Pharmaceutics. 2025 May 20;17(5):674. doi: 10.3390/pharmaceutics17050674. Pharmaceutics. 2025. PMID: 40430964 Free PMC article.
-
Mechanism of the Proprietary Chinese Medicine "JiuLiWan" to Treat Ulcerative Colitis Revealed by Network Pharmacology, Molecular Docking, and Experimental Verification In Vitro.ACS Omega. 2025 May 6;10(19):19598-19613. doi: 10.1021/acsomega.5c00261. eCollection 2025 May 20. ACS Omega. 2025. PMID: 40415848 Free PMC article.
-
Thermosensitive and pH-responsive quercus infectoria gall-containing gel with long-lasting anti-inflammatory activity for ulcerative colitis.Heliyon. 2024 Aug 13;10(19):e36225. doi: 10.1016/j.heliyon.2024.e36225. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39435110 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials